Cochrane Central Register of Controlled Trials


Within-Page Navigation

Accesskeys


end of section: to within-page navigation

Global Servicelinks

end of section: to within-page navigation

Navigation

content

Cochrane Central Register of Controlled Trials (CCTR93)
Clinical Trials

The Cochrane Central Register of Controlled Trials (Central; Clinical Trials) is a bibliography of controlled trials identified by contributers of the Cochrane Collaboration and others, as a part of an international effort to hand search the world´s journals and create an unbiased source of data for systematic reviews. Central includes reports published in conference proceedings and in many other sources not currently listed in MEDLINE or other bibliographic databases.

 

 

Database Content

Subject Coverage

Medicine and Related Fields

TypeLiterature database
LanguageEnglish
Sources

Scientific Journals, Conference proceedings, and the like

Superbases

There are predefined databases groups (superbase) for several subjects.

The database Cochrane Central Register of Controlled Trials is part of the following superbases:
XHTA, XMEDALL.

Database Resources

File Size671,683 (Status 06/2012)
File Data

You will find the number of database records in the current update status.

Update CycleMonthly

Query

Special Notes

With every update the whole file is reloaded. Therefore standing orders (SDI) are not possible.

Vocabulary

Controlled Terms (CT): MeSH thesaurus with polyhierarchical structure
Language of vocabulary: English 

The hierarchical structure of the thesaurus allows a one step search for indented descriptors using the command FIND CT DOWN … (explosion). CT can be limited using more than 80 qualifiers, e.g. epidemiology of a disease (FIND CT=.../QF=ep). List of qualifiers see appendix.

Descriptors, describing the major topics of an article are weighted and marked in the document by an asterisk (HIV SEROPOSITIVITY/*). You can search for weighted descriptors with the command FIND CT=.../W=1.

The command DISPLAY CT TREE ... displays the structure of the thesaurus.

DISPLAY CT= ...  ;ALL displays all available additional information to a descriptor (see table below).

The following additional information for controlled terms (CT) is available:

Code Field Name Description
ANN Annotations Indexing annotations
AQ Allowed Qualifier Qualifiers allowed for limiting the controlled terms
CC Classification Code One descriptor may have several classification codes corresponding to the different branches in the polyhierarchic thesaurus
CR CAS- Registry- Number  
DA Date Date, the record was added to the system
ECOM Entry Combination Information on use of combinations for related concepts
HIS History-Notes Information on entry date of the descriptor and formerly used controlled terms
MAE Major Established Introduction date as major descriptor
N1 Preferred Name Preferred name of chemicals/td>
PACT Pharmacological Action Pharmacological action descriptor
PI Previous Indexing Previous Indexing
PMN Public MeSH Note Information on entry date of the descriptor and formaerly used controlled terms
SCN Scope Notes definitions
SYN Synonym Information on entry terms
USE Use Print Version

 

Searchable Data Fields

The following document sections are considered with the free text search (FT):

Abstract (AB)
Controlled Term (CT)
Document Type (DT)
Original Title (OTI)
Title (TI)

Search language(s) in the Basic Index:   English

Data Fields, alphabetical

Explanation:

D = DISPLAY F = FIND S = SHOW
1 : front-end-masking recommended
2 : searchable word by word with field label
3 : searchable only selectively
(F): field is searchable only via basic index

  

Command Field Name Examples Notes
(F) S AB Abstract F karelia/AB Approx. 72 % of the documents contain abstracts.
D F S AU Author F AU=geraci e  
D 2 F 2 S CS Corporate Source F CS=health  
D 1 F 1 S CT Controlled Terms F CT=ibuprofen? Approx. 95 % of documents contain controlled terms. Very different field contents because of different sources, e.g. numbers as well. We recommend masking.
  /QF=... Qualifier F CT=breast neoplasms/QF=pathology Searches Controlled Terms in combination with a qualifier.
    D QF=? List of all qualifiers (see appendix).
  /W=1 Weighting F CT=hiv seropositivity/W=1 Search for weighted Controlled Terms.
Priorities were seldom established. Not useful for the search.
D 1 F 1 S CT Controlled Terms F CT=ibuprofen? Approx. 95 % of documents contain controlled terms. Very different field contents because of different sources, e.g. numbers as well. We recommend masking.
    F CT D dementia Indented descriptors are included.
    D CT T dementia Requesting tree structure.
    D CT=dementia;ALL Requesting additional information.
  /QF=... Qualifier F CT= breast neoplasms/QF= pathology    Searches Controlled Terms in combination with a qualifier.
    D QF=a Liste aller QF (siehe Anhang).
  /W=1 Weighting F CT=hiv seropositivity/W=1 Weighting of controlled terms.
D F 1 S DT Document Type F DT=guideline
D DT=?
Very different field contents because of different sources, e.g. numbers as well. We recommend masking.
D F S EDR Editor F EDR= kassell nf  
S ISS Issue Iss:  Issue 2003/1 Part of SO.
D 1 F 1 S JT Journal Title F JT=?abstracts? Contains also conferences and symposiums. Part of SO.
D F S LA Language F... AND LA=engl
D LA= ?
 
D F S ND Number of Document F ND= CN-00000777  
S NOTE Notes Note: MEDLINE - 91338646  
(F) S OTI Original Title F lunge/oti Part of TI.
S PAGE Pages PAGE: 407-11 Part of SO.
D F S PD Publication Date F PD=2003 Part of SO.
D 2 F 2 S PU Publisher F PU= springer  
D F S PY Publication Year F... AND PY>=2002 Part of PD.
S SO Source SO:  Lancet; VOL: 2 (7458); p. 291-5 /1966 Aug 6/ Consisting of JT (long title), VOL, ISS, PAGE and PD.
(F) S TI Title F asthma/TI  
S VOL Volume VOL: 23 Part of SO.
Output of Search Results

By means of the -commands: SHOW (S) / MAIL / SDI.

Corresponding to the copyright rules use the parameter USE=DLOAD if necessary.

You may ask for all data fields, single data fields, or sets of data fields. If the output fields are not specified explicitly, the standard field set (F=STD) is used in all output commands.

Fields set at output:

Command Field Set Associated Datafields
F=STD Standard Same as F=ALL
F=ALL All data fields ND, AU, TI, SO (incl. JT, ISS, PAGE, PD), LA, CS, DT, CT, NOTE, AB
F=BIB Bibliographic fields ND, AU, TI, SO, LA, CS, DT
F=DES Descriptors CT
Sample Search(es)

Subject: Asthma due to allergies

1. Search via DIMDI SmartSearch

Screenshot: CCTR93 Sample Search

2. Search via DIMDI ClassicSearch

Profile table:

Parameter Counter Number of Hits Query
C= 1 635167    CCTR93
S= 2 10445    ASTHMA/TI
S= 3 13605    CT D ASTHMA
  4 5929    (ALLERG? OR HYPERSENSITIV?)/TI
  5 1285    (2 OR 3) AND 4
Sample Record(s)

DIMDI: Cochrane Central Register of Controlled Trials (CCTR93) © The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

ND: CN-00749078
AU: Pedroletti C; Millinger E; Dahlén B; Söderman P; Zetterström O
TI: Clinical effects of purified air administered to the breathing zone in allergic asthma: A double-blind randomized cross-over trial.
SO: Respiratory medicine; VOL: 103 (9); p. 1313-9 /2009 Sep/
LA: English
CS: Department of Women and Child Health, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. christophe.pedroletti@karolinska.se
DT: REFERENCE-NEW; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
CT: Adult; Child; Female; Humans; Male; Young Adult; Administration, Inhalation; Adolescent; Air/*; Asthma/physiopathology; Asthma/*therapy; Cross-Over Studies; Double-Blind Method; Exhalation; Nitric Oxide/analysis; Nitric Oxide/*metabolism; Quality of Life/*; Sleep; Spirometry; Treatment Outcome
NOTE: PUBMED - 19443189
EMBASE - 2009403621
AB: BACKGROUND: Exposure to inhaled allergens is a pathogenetic factor in allergic asthma. However, most studies that previously looked at air cleaning devices have shown little or no effect on patients with perennial allergic asthma. AIMS AND OBJECTIVES: We examined a novel treatment using temperature regulated laminar airflow with a very low particle concentration directed to the breathing zone of teenagers and young adults with mild to moderate allergic asthma during night sleep. We hypothesised that the decreased allergen exposure during the night would have an effect on bronchial inflammation and quality of life. METHOD: Twenty-two patients (mean 18.8 years) were randomized to start with active or placebo treatment for 10 weeks. All patients received both active and placebo treatment with unfiltered air, with a 2-week wash-out period in between treatments. Maintenance treatment with inhaled corticosteroids was unaltered during the trial period. Health related quality of life (miniAQLQ) was the primary effectiveness measure. Exhaled nitric oxide (FeNO) and spirometry were also investigated. RESULTS: Active treatment resulted in an improved miniAQLQ compared to placebo (mean score 0.54, p<0.05, n=20). An effect on bronchial inflammation was also detected with significantly lower FeNO values during the active treatment period (mean -6.95 ppb, p<0.05, n=22). Both effects were evident after 5 weeks. The change in lung function was not statistically significant. CONCLUSION: Clean air, administered directly to the breathing zone during sleep, can have a positive effect on bronchial inflammation and quality of life in patients with perennial allergic asthma.

    Illustration (book): Online full-text available full text

*** End of SHOW ***

Output format: SHOW F=ALL

Contact

Producer
Contact Person

Appendix

Appendix

List of Qualifiers

Abnormalities
Administration & Dosage
Adverse Effects
Agonists
Analogs & Derivatives
Analysis
Anatomy & Histology
Antagonists & Inhibitors
Biosynthesis
Blood
Blood Supply
Cerebrospinal Fluid
Chemical Synthesis
Chemically Induced
Chemistry
Classification
Clinical Trial
Complication
Complications
Congenital
Contraindications
Cytology
Deficiency
Diagnosis
Diagnostic Use
Diet Therapy
Drug Effects
Drug Therapy
Economics
Education
Embryology
Enzymology
Epidemilogy
Ethics
Ethnology
Etiology
Genetics
Growth & Development
History
Immunology
Injuries
Innervation
Instrumentation
Isolation & Purification
Legislation & Jurisprudence
Manpower
Metabolism
Methods
Microbiology
Mortality
Nursing
Organisation & Administration
Parasitology
Pathogenicity
Pathology
Pharmacokinetics
Pharmacology
Physiology
Physiopathology
Poisoning
Prevention
Prevention & Control
Psychology
Radiation Effects
Radiography
Radionuclide Imaging
Radiotherapy
Rehabilitation
Secondary
Secretion
Standards
Statistics & Numerical Data
Supply & Distribution
Surgery
Therapeutic Use
Therapy
Toxicity
Transmission
Transplantation
Trends
Ultrasonography
Ultrastructure
Urine
Utilization
Veterinary
Virology

- Copyright: DIMDI -

All intellectual property rights of this document, also concerning reproduction and distribution, are reserved by DIMDI.